| Group | Study initiation(months) | Between-Subjects Effects | |||
---|---|---|---|---|---|---|
0 | 3 | 6 | F | P | ||
CD4% | Control (n = 4) | 39.14 ± 12.06 | 47.35 ± 7.59 | 47.93 ± 9.56 | 5.739 | 0.028* |
LTNP (n = 4) | 31.41 ± 8.04 | 31.46 ± 9.23 | 31.60 ± 8.89 | |||
Progressors (n = 4) | 21.54 ± 6.31 | 27.61 ± 5.45 | 26.40 ± 5.10 | |||
CD8% | Control (n = 4) | 25.29 ± 6.07 | 31.82 ± 4.27 | 34.41 ± 1.52 | 0.486 | 0.632 |
LTNP (n = 4) | 32.27 ± 3.03 | 39.24 ± 3.65 | 37.79 ± 7.70 | |||
Progressors (n = 4) | 32.12 ± 12.36 | 33.07 ± 10.50 | 35.08 ± 13.27 | |||
CD4/CD8 | Control (n = 4) | 1.56±0.44 | 1.49 ± 0.10 | 1.39 ± 0.26 | 21.093 | 0.001** |
LTNP (n = 4) | 0.97 ± 0.21 | 0.79 ± 0. 19 | 0.83 ± 0.11 | |||
Progressors (n = 4) | 0.69 ± 0.08 | 0.86 ± 0. 11 | 0.80 ± 0.17 |